CapyFin

Calendar Reports

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Altimmune Fiscal Q2 2013 Earnings Report - CapyFin

Altimmune

ALT · NASDAQ🇺🇸

Overview Earnings

Dividends Seasonality Metrics

Q3 2025 +5.08%Q2 2025 Q1 2025 Q4 2024 +8.08%Q3 2024 +29.52%Q2 2024 +12.18%Q1 2024 +0.84%Q4 2023 +17.69%Q3 2023 +1.12%Q2 2023 +2.03%Q1 2023 +2.21%Q4 2022 +1.86%Q3 2022 +10.32%Q2 2022 +34.99%Q1 2022 +30.96%Q4 2021 +2.18%Q3 2021 -0.46%Q2 2021 +6.60%Q1 2021 +5.16%Q4 2020 -18.59%Q3 2020 -25.06%Q2 2020 -13.45%Q1 2020 +21.35%Q4 2019 -7.08%Q3 2019 -8.00%Q2 2019 -6.45%Q1 2019 +2.72%Q4 2018 +3.45%Q3 2018 -6.82%Q2 2018 +4.86%Q1 2018 +10.77%Q4 2017 -8.30%Q3 2017 -1.03%Q2 2017 -10.30%Q1 2017 Q4 2016 Q3 2016 Q2 2016 Q1 2016 Q4 2015 Q3 2015 Q2 2015 Q1 2015 Q4 2014 Q3 2014 Q2 2014 Q1 2014 Q4 2012 Q4 2013 Q3 2013 Q2 2013 Q1 2013 Q3 2012 Q2 2012 Q1 2011 Q1 2012 Q4 2011 Q3 2011 Q2 2011 Q4 2010 Q3 2010 Q2 2010 Q1 2010

Aug 08, 2013

•

Jun 30, 2013

Altimmune Q2 2013 Earnings Report

Previous year: $6.32M

Previous year: -$0.667

Cash and Equivalents

Previous year: $11.8M

Previous year: $23.8M

Altimmune

Unlock previous datapoints

Altimmune

Unlock previous datapoints

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Company Overview

Full financial data and analysis